M, Linton K, Bruce IN, Leonard C, Bianchi S, Chaudhuri N. Drug-Induced Interstitial Lung Disease: A Systematic Review. J Clin Med. 2018 Oct 15;7(10) \[[PMC free article: PMC6209877](/pmc/articles/PMC6209877/)\] \[[PubMed: 30326612](https://pubmed.ncbi.nlm.nih.gov/30326612)\] 8. Capron F. [New classification of interstitial lung disease]. Rev Pneumol Clin. 2005 Jun;61(3):133-40. \[[PubMed: 16142185](https://pubmed.ncbi.nlm.nih.gov/16142185)\] 9. Raghu G, Nyberg F, Morgan G. The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer. 2004 Aug;91 Suppl 2(Suppl 2):S3-10. \[[PMC free article: PMC2750810](/pmc/articles/PMC2750810/)\] \[[PubMed: 15340372](https://pubmed.ncbi.nlm.nih.gov/15340372)\] 10. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994 Oct;150(4):967-72. \[[PubMed: 7921471](https://pubmed.ncbi.nlm.nih.gov/7921471)\] 11. Suki B, Stamenović D, Hubmayr R. Lung parenchymal mechanics. Compr Physiol. 2011 Jul;1(3):1317-51. \[[PMC free article: PMC3929318](/pmc/articles/PMC3929318/)\] \[[PubMed: 23733644](https://pubmed.ncbi.nlm.nih.gov/23733644)\] 12. Ryu JH, Olson EJ, Midthun DE, Swensen SJ. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin Proc. 2002 Nov;77(11):1221-7; quiz 1227. \[[PubMed: 12440558](https://pubmed.ncbi.nlm.nih.gov/12440558)\] 13. Jakubczyc A, Neurohr C. [Diagnosis and Treatment of Interstitial Lung Diseases]. Dtsch Med Wochenschr. 2018 Dec;143(24):1774-1777. \[[PubMed: 30508858](https://pubmed.ncbi.nlm.nih.gov/30508858)\] 14. Raghu G, Brown KK. Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis. Clin Chest Med. 2004 Sep;25(3):409-19, v. \[[PubMed: 15331183](https://pubmed.ncbi.nlm.nih.gov/15331183)\] 15. Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, Suzuki K, Suzuki R. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J. 2005 Mar;25(3):528-33. \[[PubMed: 15738299](https://pubmed.ncbi.nlm.nih.gov/15738299)\] 16. Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S. Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019 Mar 31;28(151) \[[PMC free article: PMC9489101](/pmc/articles/PMC9489101/)\] \[[PubMed: 30814139](https://pubmed.ncbi.nlm.nih.gov/30814139)\] 17. Kolb M, Vašáková M. The natural history of progressive fibrosing interstitial lung diseases. Respir Res. 2019 Mar 14;20(1):57. \[[PMC free article: PMC6417262](/pmc/articles/PMC6417262/)\] \[[PubMed: 30871560](https://pubmed.ncbi.nlm.nih.gov/30871560)\] 18. Sciriha A, Lungaro-Mifsud S, Fsadni P, Scerri J, Montefort S. Pulmonary Rehabilitation in patients with Interstitial Lung Disease: The effects of a 12-week programme. Respir Med. 2019 Jan;146:49-56. \[[PubMed: 30665518](https://pubmed.ncbi.nlm.nih.gov/30665518)\] **Disclosure:** Marsha Antoine declares no relevant financial relationships with ineligible companies. **Disclosure:** Mouna Mlika declares no relevant financial relationships with ineligible companies.